Selective Estrogen Receptor Modulators (SERMs) offer a unique therapeutic option for midlife and older women—blending estrogen-like benefits with targeted risk reduction. In this session, Dr. Steven R. Goldstein will explore the evolving role of SERMs in menopause management and healthy aging. He’ll review mechanisms of action, current clinical applications, and evidence for their use in symptom management, bone health, and breast safety. Attendees will gain a practical understanding of when and how to consider SERMs in the broader context of individualized menopause care.

Steven R. Goldstein, MD, Professor of Obstetrics and Gynecology at New York University School of Medicine and an Honorary Fellow of the Royal College of Obstetricians and Gynecologists, is one of the most highly recognized and regarded individuals in the field of vaginal probe ultrasound worldwide. His pioneering work in menopausal and perimenopausal ultrasound contributed to the design of uterine safety studies for Selective Estrogen Receptor Modulators (SERMS).

The recipient of numerous prestigious awards for his distinguished career in medical ultrasound, Dr. Goldstein has published seven books on women’s health topics; authored more than 60 chapters in textbooks and more than 150 original research articles; and has been a guest faculty member, invited speaker, visiting professor or course director over 400 times throughout the U.S. and the world.